EP2281037
Þáttar VII fjölpeptíð sem eru breytt og notkun þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.4.2009EP published:
11.11.2015EP application number:
09730852.2
EP translation filed:
14.12.2015Grant published:
15.1.2016EPO information:
European Patent Register
Max expiry date:
9.4.2029Expiry date:
9.4.2022
Title:
FACTOR VII POLYPEPTIDES THAT ARE MODIFIED AND USES THEREOF
Timeline
Today
10.4.2009EP application
11.11.2015EP Publication
14.12.2015Translation submitted
15.1.2016Registration published
9.4.2022Expires
Owner
Name:
Catalyst Biosciences, Inc.Address:
260 Littlefield Avenue, 94080, South San Francisco, CA, US
Inventor
Name:
MADISON, Edwin, L.Address:
San Francisco, CA, US
Name:
THANOS, ChristopherAddress:
San Francisco, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
124021 PDate:
11.4.2008Country:
US
Classification
Categories:
C12N 9/64
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 22.4.2016
Expires: 9.4.2017
Payer: Árnason Faktor
Number: 9
Paid: 25.4.2017
Expires: 9.4.2018
Payer: Árnason Faktor
Number: 10
Paid: 25.4.2018
Expires: 9.4.2019
Payer: Árnason Faktor
Number: 11
Paid: 24.4.2019
Expires: 9.4.2020
Payer: Árnason Faktor
Number: 12
Paid: 31.3.2020
Expires: 9.4.2021
Payer: Tego ehf.
Number: 13
Paid: 12.4.2021
Expires: 9.4.2022
Payer: G.H. Sigurgeirsson ehf.